The Centers for Medicare & Medicaid Services (CMS) recently mailed letters to all Medicare fee-for-service providers about work to reduce opioid misuse by people covered by Medicare. The letter touches on three initiatives including a “roadmap” to help frame the issue: co-prescribing Naloxone, new Medicare Part D opioid policies and safe and effective pain treatments. AAHKS recently issued a position statement on opioid prescribing.
Categories
- AAHKS Amplified (180)
- AAHKS Business (243)
- AAHKS Leadership (236)
- Advocacy (347)
- AJRR (64)
- Annual Meeting (582)
- Arthroplasty Topics Podcast (143)
- Awards (53)
- Bundled Payments (18)
- Certification (7)
- CME (187)
- CMS (285)
- Reimbursement (76)
- Co-Branded Meetings (66)
- Committees and Task Forces (87)
- Corporate Partners (29)
- COVID-19 (42)
- Digital Health (15)
- Digital Health Podcast (7)
- Diversity (67)
- Education (258)
- eMentor (11)
- FARE (28)
- Federal Guidelines (117)
- Fellowships (123)
- FOCAL (80)
- Foundation (19)
- Grants (47)
- Guidelines (22)
- Humanitarian Award (23)
- Humanitarian Organizations (33)
- In Memoriam (17)
- In the News (310)
- Industry (110)
- International (85)
- LEARN (22)
- Legislation (66)
- Medicare (108)
- Membership (160)
- New Orthopaedic Headquarters (5)
- News Releases (13)
- Operation Walk (14)
- Opioids (9)
- Patient Education (72)
- Patient Outcomes (72)
- Performance Measures (29)
- Popular (141)
- Position Papers (11)
- Practice Management (81)
- Promotions (39)
- Publications (169)
- Research (401)
- FARE (5)
- Residents (99)
- SEO (7)
- Social Media (11)
- Specialty Day (17)
- Spring Meeting (122)
- Surveys (58)
- Technology (29)
- The Augment Podcast (100)
- The Cut Podcast (20)
- The Match (20)
- Uncategorized (51)
- Video (10)
- Webinars (179)
- Website (19)
- Wellness (11)
- Women in Arthroplasty (47)
- Women in Arthroplasty Podcast (3)
- Young Arthroplasty Group (178)
- Young Arthroplasty Group Podcast (108)